Dr. James (Jim) A Radosevich (Ph.D.) is a Professor in the School of Dental Medicine at the University of Illinois at Chicago (UIC). From 1983 to 2004 he was an Assistant/Associate Professor and a Certified Clinical Investigator (ICH) at Northwestern University Medical School. He has consulted for numerous companies over the last thirty years, received numerous national grants/awards, and been involved in all aspects of drug development and clinical trials. Dr. Radosevich has been part of six start-up biotechnology/medical companies over the past thirty years and has a history of consistently beating performance milestones. He has held the positions of President, CEO, Chief Scientific Officer, and was the founder for five of these companies. Dr. Radosevich earned a B.S. degree in Biology at Bradley University in Peoria, Illinois in 1978 and a Ph.D. in Experimental Pathology at UIC in 1983. He completed his postdoctoral training at Northwestern University in Tumor Cell Biology, where he established.
He has edited three books, and has over four hundred published scientific papers, book chapters and abstracts, as well as 12 patents.
Research Interest: His expertise in immune recognition, immune response, and various molecular and biochemical approaches in understanding the morphology, physiology, and cell biology of human cancer. He has edited three books, and has over four hundred published scientific papers, book chapters and abstracts, as well as 12 patents.